Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Development of monoclonal antibodies specific to ribosomal protein S6 kinase 2.

Savinska L, Skorokhod O, Klipa O, Gout I, Filonenko V.

Hybridoma (Larchmt). 2012 Aug;31(4):289-94. doi: 10.1089/hyb.2012.0032.

2.

Identification of the general transcription factor Yin Yang 1 as a novel and specific binding partner for S6 kinase 2.

Ismail HM, Myronova O, Tsuchiya Y, Niewiarowski A, Tsaneva I, Gout I.

Cell Signal. 2013 May;25(5):1054-63. doi: 10.1016/j.cellsig.2013.02.002. Epub 2013 Feb 10.

PMID:
23403125
3.

Immunohistochemical analysis of S6K1 and S6K2 expression in human breast tumors.

Savinska LO, Lyzogubov VV, Usenko VS, Ovcharenko GV, Gorbenko ON, Rodnin MV, Vudmaska MI, Pogribniy PV, Kyyamova RG, Panasyuk GG, Nemazanyy IO, Malets MS, Palchevskyy SS, Gout IT, Filonenko VV.

Eksp Onkol. 2004 Mar;26(1):24-30.

PMID:
15112576
4.

S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.

Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J, Mueller M, Fumagalli S, Kozma SC, Thomas G.

Mol Cell Biol. 2004 Apr;24(8):3112-24.

5.

S6 kinase 2 is bound to chromatin-nuclear matrix cellular fractions and is able to phosphorylate histone H3 at threonine 45 in vitro and in vivo.

Ismail HM, Hurd PJ, Khalil MI, Kouzarides T, Bannister A, Gout I.

J Cell Biochem. 2014 Jun;115(6):1048-62. doi: 10.1002/jcb.24566.

PMID:
23564320
6.

Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma.

Mayevska O, Shuvayeva H, Igumentseva N, Havrylov S, Basaraba O, Bobak Y, Barska M, Volod'ko N, Baranska J, Buchman V, Drobot L.

Exp Oncol. 2006 Dec;28(4):275-81.

PMID:
17285110
7.

Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.

McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Dorfman AL, Longnus S, Pende M, Martin KA, Blenis J, Thomas G, Izumo S.

Mol Cell Biol. 2004 Jul;24(14):6231-40.

8.

Different interactomes for p70-S6K1 and p54-S6K2 revealed by proteomic analysis.

Pavan IC, Yokoo S, Granato DC, Meneguello L, Carnielli CM, Tavares MR, do Amaral CL, de Freitas LB, Paes Leme AF, Luchessi AD, Simabuco FM.

Proteomics. 2016 Oct;16(20):2650-2666. doi: 10.1002/pmic.201500249. Epub 2016 Sep 12.

PMID:
27493124
9.

Regulation of ribosomal S6 kinase 2 by effectors of the phosphoinositide 3-kinase pathway.

Martin KA, Schalm SS, Richardson C, Romanelli A, Keon KL, Blenis J.

J Biol Chem. 2001 Mar 16;276(11):7884-91. Epub 2000 Dec 6.

10.
11.

Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin.

Park IH, Bachmann R, Shirazi H, Chen J.

J Biol Chem. 2002 Aug 30;277(35):31423-9. Epub 2002 Jun 26.

12.

Involvement of heterogeneous ribonucleoprotein F in the regulation of cell proliferation via the mammalian target of rapamycin/S6 kinase 2 pathway.

Goh ET, Pardo OE, Michael N, Niewiarowski A, Totty N, Volkova D, Tsaneva IR, Seckl MJ, Gout I.

J Biol Chem. 2010 May 28;285(22):17065-76. doi: 10.1074/jbc.M109.078782. Epub 2010 Mar 22.

13.

Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2 in cardiomyocytes.

Wang L, Gout I, Proud CG.

J Biol Chem. 2001 Aug 31;276(35):32670-7. Epub 2001 Jun 28.

14.

Immunohistochemical analysis of S6K1 and S6K2 localization in human breast tumors.

Filonenko VV, Tytarenko R, Azatjan SK, Savinska LO, Gaydar YA, Gout IT, Usenko VS, Lyzogubov VV.

Exp Oncol. 2004 Dec;26(4):294-9.

PMID:
15627062
15.

In vivo role of the phosphate groove of PDK1 defined by knockin mutation.

Collins BJ, Deak M, Murray-Tait V, Storey KG, Alessi DR.

J Cell Sci. 2005 Nov 1;118(Pt 21):5023-34. Epub 2005 Oct 11.

16.

Nuclear export of S6K1 II is regulated by protein kinase CK2 phosphorylation at Ser-17.

Panasyuk G, Nemazanyy I, Zhyvoloup A, Bretner M, Litchfield DW, Filonenko V, Gout IT.

J Biol Chem. 2006 Oct 20;281(42):31188-201. Epub 2006 Aug 8.

17.

Characterization of S6K2, a novel kinase homologous to S6K1.

Lee-Fruman KK, Kuo CJ, Lippincott J, Terada N, Blenis J.

Oncogene. 1999 Sep 9;18(36):5108-14.

18.

Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.

Karlsson E, Magić I, Bostner J, Dyrager C, Lysholm F, Hallbeck AL, Stål O, Lundström P.

PLoS One. 2015 Dec 23;10(12):e0145013. doi: 10.1371/journal.pone.0145013. eCollection 2015.

19.

[Features of fibronectin-dependent activation of ribosomal protein S6 kinase (S6K1 and S6K2)].

Val'ovka TI, Filonenko VV, Velykyï MM, Drobot LB, Voterfill M, Matsuka HKh, Hut IT.

Ukr Biokhim Zh (1999). 2000 May-Jun;72(3):31-7. Ukrainian.

PMID:
11200472
20.

Receptor association and tyrosine phosphorylation of S6 kinases.

Rebholz H, Panasyuk G, Fenton T, Nemazanyy I, Valovka T, Flajolet M, Ronnstrand L, Stephens L, West A, Gout IT.

FEBS J. 2006 May;273(9):2023-36.

Supplemental Content

Support Center